Filing Details
- Accession Number:
- 0000711377-12-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-21 13:00:00
- Reporting Period:
- 2012-05-18
- Filing Date:
- 2012-05-21
- Accepted Time:
- 2012-05-21 18:09:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189021 | Edward Bradley | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-18 | 9,469 | $13.55 | 118,990 | No | 4 | M | Direct | |
Coommon Stock | Disposition | 2012-05-18 | 9,469 | $38.89 | 109,521 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2012-05-18 | 6,652 | $0.00 | 6,652 | $13.55 |
Common Stock | Common Stock (Right to Buy) | Disposition | 2012-05-18 | 2,817 | $0.00 | 2,817 | $13.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
92,857 | No | 4 | M | Direct | ||
90,040 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 14,012 | Indirect | Held in trust by Neogen 401k plan |
Footnotes
- Theses options were granted 8/9/2007 as ISO options, became exercisable in equal annual installments over a five year period,and expire on 8/9/2012
- These options were granted 8/9/2007 as NQ options, became exercisable in equal annual installments over a five year period, and expire on 8/9/2012